Clinical Trial: Clinical Study of HRS-2129 for Acute Gouty Arthritis

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07706777) titled 'Clinical Study of HRS-2129 for Acute Gouty Arthritis' on July 07.

Brief Summary: The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Acute Gouty Arthritis

Intervention: DRUG: HRS-2129 Tablet

HRS-2129 Tablet; high dose

DRUG: HRS-2129 Tablet

HRS-2129 Tablet; low dose

DRUG: Placebo

HRS-2129 Tablet Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong Suncadia Medicine Co., Ltd.

Published by HT Digital Content Services with...